FDA Inspection 1072371 — Henry Cyster
The FDA completed an inspection of Henry Cyster on Nov 2, 2018 in Parow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 2, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Parow (South Africa)
Additional Details
Clinical Investigator (CI)